Skip to main content

Education/ACR/EULAR

    RT @Dr_C_Koutsianas: Do not be tempted to stop MTX or other DMARDs perioperatively! They probably help rather than harm
    3 years 10 months ago
    Do not be tempted to stop MTX or other DMARDs perioperatively! They probably help rather than harm #EULAR2020 https://t.co/jb4ZuZlqSu
    RA pt not responding to a 1st biologic; what you predict in a Head to Head - Abatacept vs Upadacitinib?
    3 years 10 months ago
    RA pt not responding to a 1st biologic; what you predict in a Head to Head - Abatacept vs Upadacitinib?
    RT @DrPetryna: #EULAR2020 #op0225 sub study of OPAL Balance: withdrawal of MTxdoes not negatively impact Tofa efficacy i
    3 years 10 months ago
    #EULAR2020 #op0225 sub study of OPAL Balance: withdrawal of MTxdoes not negatively impact Tofa efficacy in PsA. At 6 mo deltaPASDAS 0.229 (0.079) for tofa mono & 0.q138 (0.081) for tofa+mtx. LFT elevation more common in combination arm @RheumNow https://t.co/NO1agViScD
    RT @DrPetryna: #EULAR2020 #fri0505 Still’s pts who are able to achieve remissions w/longer itnervals btw tocilizumab i
    3 years 10 months ago
    #EULAR2020 #fri0505 Still’s pts who are able to achieve remissions w/longer itnervals btw tocilizumab infusions & lower dose of prednisone more likely to successfully withdraw Toci. Time to symptom recurrence in relapse group 7.8 mo. Older pts more likely to relapse @RheumNow
    RT @DrAiLynTan: Main factors influencing #physicalactivity in inflammatory #arthritis patients are psychological

    ➡️
    3 years 10 months ago
    Main factors influencing #physicalactivity in inflammatory #arthritis patients are psychological ➡️Main factor related to knowledge of benefits of #exercise & symptoms ➡️Modifiable ➡️Health professional support key FRI0642-HPR #EULAR2020 👉🏽https://t.co/Vdc7rjnC6Y by @DavergneT https://t.co/aMUHA5IMrn
    RT @DrPetryna: @Janetbirdope @eular_org @RheumNow @CRASCRRheum @earlyarthritis Good question. I suspect it may be a clas
    3 years 10 months ago
    @Janetbirdope @eular_org @RheumNow @CRASCRRheum @earlyarthritis Good question. I suspect it may be a class effect but would be good to see H2H btw JAKs one day. If selective JAK 1 inhibition provides more, less or same efficacy is still not clear to me
    RT @Janetbirdope: Don’t forget significant fibrosis with ILD has +RCT with nintedanib INBUILD study. Lots of buzz of R
    3 years 10 months ago
    Don’t forget significant fibrosis with ILD has +RCT with nintedanib INBUILD study. Lots of buzz of RA ILD where MTX is OK, TNFi may have more ILD than other bDMARDs, biomatkers KL-6 @eular_org OP0038 #EULAR2020 @CRASCRRheum https://t.co/OihF3LmNYQ
    RT @KDAO2011: #EULAR2020 OP0096 Dr. L Chatzis study on Sjogren:
    1. 2nd most common autoimm dz in women
    2. women:men rat
    3 years 10 months ago
    #EULAR2020 OP0096 Dr. L Chatzis study on Sjogren: 1. 2nd most common autoimm dz in women 2. women:men ratio 20:1 (not 9:1) 3. 2 types Ro-Ab: nuc. Ro60 (assc w/La)and cytopls. Ro52 (assc w/ILD/myositis) 4. Seroneg. Sjogren's (neg Ro/La/RF) good prognosis:⬇️lymphoma @RheumNow https://t.co/fV3ltQqnkf
    RT @Janetbirdope: NPSLE is more than a headache! probs with dx, uncertain Rx, overlap with common probs - infection, pai
    3 years 10 months ago
    NPSLE is more than a headache! probs with dx, uncertain Rx, overlap with common probs - infection, pain, fibromyalgia, drug side effects, etc. Spectrum in NPSLE just like SLE has a spectrum of cutaneous findings T Huizanga discusses @eular_org #EULAR2020 @RheumNow @CRASCRRheum https://t.co/sdw0xavWBq